L-Carnosine inhibits and degrades AGEs, hence maintaining the structural integrity of the skin and organs
In order to address this limitation, we implemented a fairly strict definition of GLP-1 use to include patients in the treatment cohort: medication orders indicated 12 continuous months of prescribed GLP-1 use
It is, therefore, important to have liver-specific treatments for patients who have already advanced liver disease
Oral bioavailability studies in rats show systemic effects even when administered per os, suggesting meaningful absorption through the GI mucosa
PMCID: PMC7108996 Andersen NB, Malmlf K, Johansen PB, Andreassen TT, rtoft G, Oxlund H
Some patients may still need in-office care, lab work, or additional evaluation depending on medical needs